Alzheimers New Drug Approved by FDA Storyboard
Aramak

Alzheimers New Drug Approved by FDA

Bu Öykü Panosunu kopyala
Alzheimers New Drug Approved by FDA

Öykü Açıklama

PME 815

Öykü Penceresi Metni

  • Slayt: 1
  • News Stand
  • “Alzheimer’s Cure Approved by FDA – Only One Pill Needed!”
  • Slayt: 2
  • “Wow, I should share this!” -- Texts a friend
  • Slayt: 3
  • “Are you sure it’s real? We should use facts checking tools, try to find the original source and verify and check other sources just to make sure.”
  • Skepticism ensues....
  • Slayt: 4
  • Searches for information on the FDA’s website, discovering that the new Alzheimer’s treatment, Lecanemab, is not a cure and has limitations.
  • FDA
  • Slayt: 5
  • Let's consult the Mayo Clinic . They found that Lecanemab slows symptoms in early cases but has severe risks, including brain swelling.
  • Slayt: 6
  • “Imagine if social media flagged questionable health news and provided a ‘Read More’ option to check reliable sources.”
  • Maybe platforms could highlight credible sources when using information from them .
  • Slayt: 7
  • Another source shows the drug costs $26,500 annually. That’s not affordable for everyone, jeepers!
  • Slayt: 8
  • So basically, Lecanemab helps some early-stage patients but isn’t a cure, comes with risks, and is expensive.
  • Slayt: 9
  • “To be a responsible digital citizen, always verify health claims and question headlines.”
  • Slayt: 10
  • Sources:Alzheimer's Association. “Donanemab for Treatment of Early Alzheimer’s Disease — News Pending FDA Review.” Alzheimer’s Disease and Dementia, 2023, www.alz.org/alzheimers-dementia/treatments/donanemab. Canadian Teachers’ Federation. (2021, February 22). Break the fake [Video]. YouTube. https://www.youtube.com/watch?v=qHeNabULAE0 Salam, Erum. “FDA Approves Breakthrough Alzheimer’s Drug Lecanemab.” The Guardian, 6 Jan. 2023, www.theguardian.com/us-news/2023/jan/06/fda-approves-breakthrough-alzheimers-drug-lecanemab.Stiepan, DeeDee. “Alzheimer’s Drug Lecanemab Granted Full Approval by FDA, Mayo Clinic Expert Weighs In.” Mayo Clinic News Network, 6 July 2023, newsnetwork.mayoclinic.org/discussion/alzheimers-drug-lecanemab-granted-full-approval-by-fda-mayo-clinic-expert-weighs-in/.
40 Milyondan Fazla Hikaye Panosu Oluşturuldu
İndirme Yok, Kredi Kartı Yok ve Denemek İçin Giriş Gerekmiyor!
Storyboard That Aile Storyboard